Markers of periodontal diseases and sensitivity to taromentine in patients with aggressive periodontitis

The aim of the research was to study sensitivity of specific microorganisms from the periodontal pockets of patients with rapidly progressive periodontal disease to Taromentine. 95 patients aged 21 to 35 years (50 women (52,6+/-33,62) and 45 men (47,36+/-3,62)) with rapidly progressive form of perio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Georgian medical news 2009-04 (169), p.29-32
Hauptverfasser: Iverieli, M V, Abashidze, N O, Gogishvili, Kh B
Format: Artikel
Sprache:rus
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 32
container_issue 169
container_start_page 29
container_title Georgian medical news
container_volume
creator Iverieli, M V
Abashidze, N O
Gogishvili, Kh B
description The aim of the research was to study sensitivity of specific microorganisms from the periodontal pockets of patients with rapidly progressive periodontal disease to Taromentine. 95 patients aged 21 to 35 years (50 women (52,6+/-33,62) and 45 men (47,36+/-3,62)) with rapidly progressive form of periodontal desease were observed. Porphiromonas gingivalis was identifide in 83 out of 95 patients (87,36+/-2,06). Prevotella intermedia - in 31 patients (32,6+/-2,750); Actinobacillus actinomycetemcomitans - in 23 patients (24,2+/-2,050); Bacteroides forsythus - in 19 patients (20,0+/-2,360); Treponema denticola - in 16 patients (16,84+/-2,190); Candida - in 11 patients (11,57+/-1,80). The sensitivity of all cultures to Taromentine was investigated: 134 (77,9+/-1,89) out of 183 identified markers demonstrated sensitivity to Taromentine. Demostrated sensitivity to Taromentine: 64 (37,2+/-1,06) out of 83 identified cultures of Porphiromonas gingivalis, 24 (13,95+/-1,85) out of 31 identified cultures of Prevotela intermedia, 18 (10,47+/-1,05) out of 23 identified cultures of Actinobacillus actinomycetemcomitans, 15 (8,7+/-1,86) out of 19 identified cultures of Bacteroides forsythus, and 13 (7,84+/-1,09) out of 16 identified cultures of Treponema denticola. Totally 38 (22,1+/-1,59) out of 172 identified periodontal markers demonstrated resistence to Taromentine. The results of analysis showed that Taromentine could be recommended in complex treatment of periodontal diseases.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67220637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67220637</sourcerecordid><originalsourceid>FETCH-LOGICAL-p549-9ed5d1810f91151c8ea788bc73b30ce58ffaba89b7d1771ba670610378d4f7ea3</originalsourceid><addsrcrecordid>eNpFUE1rwzAU82FjLV3_wvBpt4AdJ7FzHGVf0LFL7-Elfmm9JXbm53b03y-wjukiBJJAumJLWco8E1LmC7Ym-hAzyqIysrhhC1kXSghVL9nhDeInRuKh5xNGF2zwCQZuHSEQEgdvOaEnl9zJpTNPgSeIYUSfnEfuPJ8guVkR_3bpwGG_j0jkTvjfN2fpll33MBCuL7xiu6fH3eYl274_v24ettlUFnVWoy2tNFL0tZwHdAZBG9N2WrVKdFiavocWTN1qK7WWLVRaVFIobWzRawS1Yve_tVMMX0ek1IyOOhwG8BiO1FQ6z0Wl9Gy8uxiP7Yi2maIbIZ6bv2vUD4iEYkk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67220637</pqid></control><display><type>article</type><title>Markers of periodontal diseases and sensitivity to taromentine in patients with aggressive periodontitis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Iverieli, M V ; Abashidze, N O ; Gogishvili, Kh B</creator><creatorcontrib>Iverieli, M V ; Abashidze, N O ; Gogishvili, Kh B</creatorcontrib><description>The aim of the research was to study sensitivity of specific microorganisms from the periodontal pockets of patients with rapidly progressive periodontal disease to Taromentine. 95 patients aged 21 to 35 years (50 women (52,6+/-33,62) and 45 men (47,36+/-3,62)) with rapidly progressive form of periodontal desease were observed. Porphiromonas gingivalis was identifide in 83 out of 95 patients (87,36+/-2,06). Prevotella intermedia - in 31 patients (32,6+/-2,750); Actinobacillus actinomycetemcomitans - in 23 patients (24,2+/-2,050); Bacteroides forsythus - in 19 patients (20,0+/-2,360); Treponema denticola - in 16 patients (16,84+/-2,190); Candida - in 11 patients (11,57+/-1,80). The sensitivity of all cultures to Taromentine was investigated: 134 (77,9+/-1,89) out of 183 identified markers demonstrated sensitivity to Taromentine. Demostrated sensitivity to Taromentine: 64 (37,2+/-1,06) out of 83 identified cultures of Porphiromonas gingivalis, 24 (13,95+/-1,85) out of 31 identified cultures of Prevotela intermedia, 18 (10,47+/-1,05) out of 23 identified cultures of Actinobacillus actinomycetemcomitans, 15 (8,7+/-1,86) out of 19 identified cultures of Bacteroides forsythus, and 13 (7,84+/-1,09) out of 16 identified cultures of Treponema denticola. Totally 38 (22,1+/-1,59) out of 172 identified periodontal markers demonstrated resistence to Taromentine. The results of analysis showed that Taromentine could be recommended in complex treatment of periodontal diseases.</description><identifier>ISSN: 1512-0112</identifier><identifier>PMID: 19430039</identifier><language>rus</language><publisher>Georgia (Republic)</publisher><subject>Adult ; Amoxicillin - therapeutic use ; Anti-Infective Agents - therapeutic use ; Bacteria - drug effects ; Bacteria - isolation &amp; purification ; Biomarkers ; Drug Resistance, Bacterial ; Female ; Humans ; Male ; Periodontitis - drug therapy ; Periodontitis - microbiology ; Treatment Outcome ; Young Adult</subject><ispartof>Georgian medical news, 2009-04 (169), p.29-32</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19430039$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iverieli, M V</creatorcontrib><creatorcontrib>Abashidze, N O</creatorcontrib><creatorcontrib>Gogishvili, Kh B</creatorcontrib><title>Markers of periodontal diseases and sensitivity to taromentine in patients with aggressive periodontitis</title><title>Georgian medical news</title><addtitle>Georgian Med News</addtitle><description>The aim of the research was to study sensitivity of specific microorganisms from the periodontal pockets of patients with rapidly progressive periodontal disease to Taromentine. 95 patients aged 21 to 35 years (50 women (52,6+/-33,62) and 45 men (47,36+/-3,62)) with rapidly progressive form of periodontal desease were observed. Porphiromonas gingivalis was identifide in 83 out of 95 patients (87,36+/-2,06). Prevotella intermedia - in 31 patients (32,6+/-2,750); Actinobacillus actinomycetemcomitans - in 23 patients (24,2+/-2,050); Bacteroides forsythus - in 19 patients (20,0+/-2,360); Treponema denticola - in 16 patients (16,84+/-2,190); Candida - in 11 patients (11,57+/-1,80). The sensitivity of all cultures to Taromentine was investigated: 134 (77,9+/-1,89) out of 183 identified markers demonstrated sensitivity to Taromentine. Demostrated sensitivity to Taromentine: 64 (37,2+/-1,06) out of 83 identified cultures of Porphiromonas gingivalis, 24 (13,95+/-1,85) out of 31 identified cultures of Prevotela intermedia, 18 (10,47+/-1,05) out of 23 identified cultures of Actinobacillus actinomycetemcomitans, 15 (8,7+/-1,86) out of 19 identified cultures of Bacteroides forsythus, and 13 (7,84+/-1,09) out of 16 identified cultures of Treponema denticola. Totally 38 (22,1+/-1,59) out of 172 identified periodontal markers demonstrated resistence to Taromentine. The results of analysis showed that Taromentine could be recommended in complex treatment of periodontal diseases.</description><subject>Adult</subject><subject>Amoxicillin - therapeutic use</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - isolation &amp; purification</subject><subject>Biomarkers</subject><subject>Drug Resistance, Bacterial</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Periodontitis - drug therapy</subject><subject>Periodontitis - microbiology</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>1512-0112</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUE1rwzAU82FjLV3_wvBpt4AdJ7FzHGVf0LFL7-Elfmm9JXbm53b03y-wjukiBJJAumJLWco8E1LmC7Ym-hAzyqIysrhhC1kXSghVL9nhDeInRuKh5xNGF2zwCQZuHSEQEgdvOaEnl9zJpTNPgSeIYUSfnEfuPJ8guVkR_3bpwGG_j0jkTvjfN2fpll33MBCuL7xiu6fH3eYl274_v24ettlUFnVWoy2tNFL0tZwHdAZBG9N2WrVKdFiavocWTN1qK7WWLVRaVFIobWzRawS1Yve_tVMMX0ek1IyOOhwG8BiO1FQ6z0Wl9Gy8uxiP7Yi2maIbIZ6bv2vUD4iEYkk</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Iverieli, M V</creator><creator>Abashidze, N O</creator><creator>Gogishvili, Kh B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200904</creationdate><title>Markers of periodontal diseases and sensitivity to taromentine in patients with aggressive periodontitis</title><author>Iverieli, M V ; Abashidze, N O ; Gogishvili, Kh B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p549-9ed5d1810f91151c8ea788bc73b30ce58ffaba89b7d1771ba670610378d4f7ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>rus</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Amoxicillin - therapeutic use</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - isolation &amp; purification</topic><topic>Biomarkers</topic><topic>Drug Resistance, Bacterial</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Periodontitis - drug therapy</topic><topic>Periodontitis - microbiology</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iverieli, M V</creatorcontrib><creatorcontrib>Abashidze, N O</creatorcontrib><creatorcontrib>Gogishvili, Kh B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Georgian medical news</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iverieli, M V</au><au>Abashidze, N O</au><au>Gogishvili, Kh B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Markers of periodontal diseases and sensitivity to taromentine in patients with aggressive periodontitis</atitle><jtitle>Georgian medical news</jtitle><addtitle>Georgian Med News</addtitle><date>2009-04</date><risdate>2009</risdate><issue>169</issue><spage>29</spage><epage>32</epage><pages>29-32</pages><issn>1512-0112</issn><abstract>The aim of the research was to study sensitivity of specific microorganisms from the periodontal pockets of patients with rapidly progressive periodontal disease to Taromentine. 95 patients aged 21 to 35 years (50 women (52,6+/-33,62) and 45 men (47,36+/-3,62)) with rapidly progressive form of periodontal desease were observed. Porphiromonas gingivalis was identifide in 83 out of 95 patients (87,36+/-2,06). Prevotella intermedia - in 31 patients (32,6+/-2,750); Actinobacillus actinomycetemcomitans - in 23 patients (24,2+/-2,050); Bacteroides forsythus - in 19 patients (20,0+/-2,360); Treponema denticola - in 16 patients (16,84+/-2,190); Candida - in 11 patients (11,57+/-1,80). The sensitivity of all cultures to Taromentine was investigated: 134 (77,9+/-1,89) out of 183 identified markers demonstrated sensitivity to Taromentine. Demostrated sensitivity to Taromentine: 64 (37,2+/-1,06) out of 83 identified cultures of Porphiromonas gingivalis, 24 (13,95+/-1,85) out of 31 identified cultures of Prevotela intermedia, 18 (10,47+/-1,05) out of 23 identified cultures of Actinobacillus actinomycetemcomitans, 15 (8,7+/-1,86) out of 19 identified cultures of Bacteroides forsythus, and 13 (7,84+/-1,09) out of 16 identified cultures of Treponema denticola. Totally 38 (22,1+/-1,59) out of 172 identified periodontal markers demonstrated resistence to Taromentine. The results of analysis showed that Taromentine could be recommended in complex treatment of periodontal diseases.</abstract><cop>Georgia (Republic)</cop><pmid>19430039</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1512-0112
ispartof Georgian medical news, 2009-04 (169), p.29-32
issn 1512-0112
language rus
recordid cdi_proquest_miscellaneous_67220637
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adult
Amoxicillin - therapeutic use
Anti-Infective Agents - therapeutic use
Bacteria - drug effects
Bacteria - isolation & purification
Biomarkers
Drug Resistance, Bacterial
Female
Humans
Male
Periodontitis - drug therapy
Periodontitis - microbiology
Treatment Outcome
Young Adult
title Markers of periodontal diseases and sensitivity to taromentine in patients with aggressive periodontitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A11%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Markers%20of%20periodontal%20diseases%20and%20sensitivity%20to%20taromentine%20in%20patients%20with%20aggressive%20periodontitis&rft.jtitle=Georgian%20medical%20news&rft.au=Iverieli,%20M%20V&rft.date=2009-04&rft.issue=169&rft.spage=29&rft.epage=32&rft.pages=29-32&rft.issn=1512-0112&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E67220637%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67220637&rft_id=info:pmid/19430039&rfr_iscdi=true